Question 1

What are the specific side effects of ziprasidone that we should be aware of?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Study of the Safety and Tolerability of Oral Ziprasidone in Children and Teens With Psychotic Disorders clinical trial (NCT00650611). Contact the study team or your healthcare provider for specific answers.

Question 2

How will we monitor my child's response to the medication during the trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Study of the Safety and Tolerability of Oral Ziprasidone in Children and Teens With Psychotic Disorders clinical trial (NCT00650611). Contact the study team or your healthcare provider for specific answers.

Question 3

What happens if my child needs to stop taking ziprasidone during the study?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Study of the Safety and Tolerability of Oral Ziprasidone in Children and Teens With Psychotic Disorders clinical trial (NCT00650611). Contact the study team or your healthcare provider for specific answers.

Question 4

Are there other treatment options available that might be more suitable for my child?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Study of the Safety and Tolerability of Oral Ziprasidone in Children and Teens With Psychotic Disorders clinical trial (NCT00650611). Contact the study team or your healthcare provider for specific answers.

Question 5

How will this trial affect my child's daily routine and school activities?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Study of the Safety and Tolerability of Oral Ziprasidone in Children and Teens With Psychotic Disorders clinical trial (NCT00650611). Contact the study team or your healthcare provider for specific answers.

Question 6

What support will be available for my child during the trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Study of the Safety and Tolerability of Oral Ziprasidone in Children and Teens With Psychotic Disorders clinical trial (NCT00650611). Contact the study team or your healthcare provider for specific answers.

What this study is about